CVS Health Corp header image

CVS Health Corp

CVS

Equity

ISIN null / Valor 548525

New York Stock Exchange, Inc (2026-11-11)
USD 88.29-0.80%

CVS Health Corp
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

CVS Health Corporation is a diversified healthcare company whose operations span retail pharmacy, pharmacy benefits management, and health insurance: it operates a large chain of retail pharmacies and in-store clinics (MinuteClinic/HealthHUB), dispenses prescriptions including specialty and long-term care medications, manages prescription drug benefits for employers and public programs through its CVS Caremark PBM, and provides medical and pharmacy coverage through its Aetna health insurance business. The company generates revenue from retail sales and prescription dispensing, PBM administrative and formulary services, specialty pharmacy and infusion services, and insurance premiums, while also offering care-delivery services such as walk‑in clinics and some telehealth and home‑health capabilities, positioning it as an integrated participant across multiple points of the U.S. healthcare value chain.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

14.8%1Y
31.5%3Y
-4.25%5Y

Performance

34.7%1Y
34.6%3Y
31.3%5Y

Volatility

Market cap

113886 M

Market cap (USD)

Daily traded volume (Shares)

15,116,052

Daily traded volume (Shares)

1 day high/low

44.4 / 43.66

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
3.00
Kyan Bailey
UK, 04 Nov 2026
star star star star star
Strong Q3 results, with adjusted EPS of $2.09 beating $1.65 expectations and revenue rising 5.4% to $108.4bn.

EQUITIES OF THE SAME SECTOR

STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 257.12
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.39%CHF 71.20
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%USD 206.35
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.07
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC Valor: 14769757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.77%USD 245.43
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.42%USD 30.92
Addex Therapeutics Ltd
Addex Therapeutics Ltd Addex Therapeutics Ltd Valor: 2985075
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.93%CHF 0.022
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 523134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.92%USD 22.74
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited Valor: 12029898
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.42%INR 1,905.00
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.40%INR 1,017.95